Skip to content
10-Q

Quarterly Report

Anacor Pharmaceuticals, Inc.

0001104659-15-057715

← back to feed
Filed
Aug 7, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 3, 2015 44.02M sh
Capex Q2 2015 · Jun 30, 2015 $387K
Capex Q2 2015 · Jun 30, 2014 $358K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $7.49M
Cash And Equivalents Q2 2015 · Dec 31, 2014 $15.99M
Cash And Equivalents Q2 2015 · Jun 30, 2014 $19.96M
Cash And Equivalents Q2 2015 · Dec 31, 2013 $114.76M
Stockholders Equity Q2 2015 · Jun 30, 2015 $65.28M
Stockholders Equity Q2 2015 · Dec 31, 2014 $78.83M
Current Liabilities Q2 2015 · Jun 30, 2015 $29.16M
Current Liabilities Q2 2015 · Dec 31, 2014 $28.65M
Current Assets Q2 2015 · Jun 30, 2015 $181.81M
Current Assets Q2 2015 · Dec 31, 2014 $160.57M
Total Assets Q2 2015 · Jun 30, 2015 $195.78M
Total Assets Q2 2015 · Dec 31, 2014 $209.05M
Sga Expense Q2 2015 · Jun 30, 2015 $13.99M
Sga Expense Q2 2015 · Jun 30, 2015 $22.13M
Sga Expense Q2 2015 · Jun 30, 2014 $7.1M
Sga Expense Q2 2015 · Jun 30, 2014 $15.42M
Rd Expense Q2 2015 · Jun 30, 2015 $18.67M
Rd Expense Q2 2015 · Jun 30, 2015 $36.83M
Rd Expense Q2 2015 · Jun 30, 2014 $19.26M
Rd Expense Q2 2015 · Jun 30, 2014 $35.2M
Operating Income Q2 2015 · Jun 30, 2015 −$12M
Operating Income Q2 2015 · Jun 30, 2015 −$23.79M
Operating Income Q2 2015 · Jun 30, 2014 −$23.43M
Operating Income Q2 2015 · Jun 30, 2014 −$43.53M
Cost Of Revenue Q2 2015 · Jun 30, 2015 $680K
Cost Of Revenue Q2 2015 · Jun 30, 2015 $1.43M
Revenue Q2 2015 · Jun 30, 2015 $21.34M
Revenue Q2 2015 · Jun 30, 2015 $36.6M
Revenue Q2 2015 · Jun 30, 2014 $2.93M
Revenue Q2 2015 · Jun 30, 2014 $7.09M